HC Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,694
Closed -$319K 87
2022
Q1
$319K Sell
2,694
-1,691
-39% -$200K 0.2% 59
2021
Q4
$604K Buy
4,385
+694
+19% +$95.6K 0.37% 41
2021
Q3
$513K Sell
3,691
-582
-14% -$80.9K 0.34% 42
2021
Q2
$415K Sell
4,273
-230
-5% -$22.3K 0.26% 50
2021
Q1
$308K Buy
4,503
+782
+21% +$53.5K 0.2% 57
2020
Q4
$319K Buy
3,721
+320
+9% +$27.4K 0.22% 60
2020
Q3
$221K Buy
+3,401
New +$221K 0.18% 65